Cistracurium Besylate 10 mg/mL Solution Compounded in a Hospital Pharmacy to Prevent Drug Shortages: A Stability Study Involving Four Degradation Products

Background: Stability study of a 10 mg/mL injectable cisatracurium solution stored refrigerated in amber glass ampoules for 18 months (M18). Methods: 4000 ampoules were aseptically compounded using European Pharmacopoeia (EP)-grade cisatracurium besylate, sterile water for injection, and benzenesulf...

Descripción completa

Detalles Bibliográficos
Autores principales: Roche, Marine, Danel, Cécile, Simon, Nicolas, Kouach, Mostafa, Bouchfaa, Myriam, Berneron, Christophe, Odou, Pascal, Lannoy, Damien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221331/
https://www.ncbi.nlm.nih.gov/pubmed/37242646
http://dx.doi.org/10.3390/pharmaceutics15051404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221331/
https://www.ncbi.nlm.nih.gov/pubmed/37242646
http://dx.doi.org/10.3390/pharmaceutics15051404

Ejemplares similares